It triggered early ERS followed by apoptosis and autophagy in a series of melanoma cell lines, including patient-derived melanocytes resistant to BRAF inhibitors, and suppressed the growth of BRAF-resistant melanoma xenografts in mice [236]. This evidence concerns the gene BRAF and melanoma.